Drug Trial Radar · NCT06531538
A Study to Learn About How a New Pneumococcal Vaccine Works in Children
Last checked: Nov 19, 2026Latest source record: Mar 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
225
Actual
Start
Jul 30, 2024
Primary completion
Feb 9, 2026
Study completion Feb 9, 2026
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Aug 1, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 months, up to 15 months
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to learn about the safety, tolerability and immune effects of a pneumococcal vaccine in toddlers. Participants will take part in this study for approximately 6 or 8 months depending on which group they are assigned to. During this time participants will have 2 clinic visits and 1 phone visit for the 1-Dose group, or 3 clinic visits and 1 phone visit for the 2-Dose group. At these clinic visits, participants will be asked if any side effects were experienced. The participants will also have to give blood samples during some clinic visits.
Conditions
- Pneumococcal Disease
Interventions
PG4Biological
Multivalent pneumococcal conjugate vaccine.
20-valent pneumococcal conjugate vaccine (20vPnC)Biological
20-valent pneumococcal conjugate vaccine (20vPnC)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of participants reporting prespecified local reactions within 7 days after each doseTime frame: 7 days after each dose
- Percentage of participants reporting prespecified systemic events within 7 days after each doseTime frame: 7 days after each dose
- Percentage of participants reporting Adverse Events (AEs) within 1 month after the last assigned vaccinationTime frame: From signing of ICD to 1 month after last assigned vaccination
- Percentage of participants reporting Serious Adverse Events (SAEs) within 6 months after vaccinationTime frame: From signing of ICD to 6 months after last assigned vaccination
Locations
39 sites in 2 countries. Site status is shown where the registry gives one.
Emerson Clinical Research Institute
Washington D.C., District of Columbia
Bio-Medical Research LLC
Miami, Florida
Tekton Research, LLC.
Chamblee, Georgia
Javara - Privia Medical Group Georgia - Fayetteville
Fayetteville, Georgia
Rophe Adult and Pediatric Medicine/SKYCRNG
Union City, Georgia
The Iowa Clinic
Ankeny, Iowa
Louisiana State University Health Sciences Shreveport - Fairfield avenue
Shreveport, Louisiana
Louisiana State University Health Sciences Shreveport
Shreveport, Louisiana
Ochsner/LSU Health Ambulatory Care Center
Shreveport, Louisiana
University of Maryland, Baltimore - Institutional Review Board
Baltimore, Maryland
University of Maryland, Baltimore, Center for Vaccine Development and Global Health
Baltimore, Maryland
The Pediatric Center
Columbia, Maryland
Atrium Health - Strive Vaccine Research Clinic
Charlotte, North Carolina
Atrium Health-Myers Park
Charlotte, North Carolina
Duke Vaccine and Trials Unit
Durham, North Carolina
Durham Pediatrics at North Duke Street
Durham, North Carolina
Duke University
Durham, North Carolina
Atrium Health-Matthews
Matthews, North Carolina
Senders Pediatrics
South Euclid, Ohio
Carolina Family Care
Charleston, South Carolina
MUSC Children's Health
Charleston, South Carolina
Carolina Family Care
Summerville, South Carolina
MUSC Children's Health
Summerville, South Carolina
Holston Medical Group
Kingsport, Tennessee
Pediatric Clinical Trials of Tennessee, LLC
Tullahoma, Tennessee
Javara - Privia Medical Group North Texas - Dallas
Dallas, Texas
Oak Cliff Research Company, LLC
Dallas, Texas
Oak Cliff Research Company, LLC
Dallas, Texas
Mercury Clinical Research - Houston
Houston, Texas
DM Clinical Research - Kool Kids Pediatrics
Houston, Texas
Kool Kids Pediatrics
Houston, Texas
Mercury Clinical Research - Sunrise Pediatrics
Houston, Texas
Mercury Clinical Research - Pediatric Associates
Houston, Texas
University of Texas Medical Branch
League City, Texas
Mercury Clinical Research - North Houston Internal Medicine & Pediatric Clinic
Tomball, Texas
Ponce Medical School Foundation Inc.
Ponce, Puerto Rico
BRCR Medical Center - Ponce
Ponce, Puerto Rico
BRCR Global Puerto Rico
San Juan, Puerto Rico
CMRC Headlands, LLC
San Juan, Puerto Rico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.